263 related articles for article (PubMed ID: 125040)
1. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease.
DeVane GW; Czekala NM; Judd HL; Yen SS
Am J Obstet Gynecol; 1975 Feb; 121(4):496-500. PubMed ID: 125040
[TBL] [Abstract][Full Text] [Related]
2. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
Judd HL; Rigg LA; Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
[TBL] [Abstract][Full Text] [Related]
3. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
4. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.
Lobo RA; Granger L; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1981 Jan; 52(1):156-8. PubMed ID: 6778890
[TBL] [Abstract][Full Text] [Related]
5. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
[TBL] [Abstract][Full Text] [Related]
7. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
Lobo RA; Kletzky OA; Campeau JD; diZerega GS
Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
[TBL] [Abstract][Full Text] [Related]
8. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
10. Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, estrogens, and progestins with physical changes.
Lee PA; Xenakis T; Winer J; Matsenbaugh S
J Clin Endocrinol Metab; 1976 Oct; 43(4):775-84. PubMed ID: 135768
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries.
Fox R; Corrigan E; Thomas PG; Hull MG
Br J Obstet Gynaecol; 1991 Mar; 98(3):294-9. PubMed ID: 1827032
[TBL] [Abstract][Full Text] [Related]
12. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist.
Chang RJ; Laufer LR; Meldrum DR; DeFazio J; Lu JK; Vale WW; Rivier JE; Judd HL
J Clin Endocrinol Metab; 1983 May; 56(5):897-903. PubMed ID: 6403570
[TBL] [Abstract][Full Text] [Related]
13. Puberty in boys: correlation of plasma levels of gonadotropins (LH, FSH), androgens (testosterone, androstenedione, dehydroepiandrosterone and its sulfate), estrogens (estrone and estradiol) and progestins (progesterone and 17-hydroxyprogesterone).
Lee PA; Migeon CJ
J Clin Endocrinol Metab; 1975 Sep; 41(3):556-62. PubMed ID: 125762
[TBL] [Abstract][Full Text] [Related]
14. Endocrinological meaning of hyperandrogenism in patients with polycystic ovary.
Takahashi K; Eda Y; Kusakari M; Yoshino K; Kitao M
Gynecol Obstet Invest; 1991; 31(1):46-50. PubMed ID: 2010114
[TBL] [Abstract][Full Text] [Related]
15. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of bromocriptine on gonadotropin secretion in polycystic ovary syndrome.
Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Fossati P
Fertil Steril; 1985 Sep; 44(3):356-60. PubMed ID: 3161758
[TBL] [Abstract][Full Text] [Related]
17. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome.
Caanen MR; Kuijper EA; Hompes PG; Kushnir MM; Rockwood AL; Meikle WA; Homburg R; Lambalk CB
Eur J Endocrinol; 2016 Jan; 174(1):25-32. PubMed ID: 26586837
[TBL] [Abstract][Full Text] [Related]
19. Peripheral steroid-gonadotropin interactions and diagnostic significance of double-stimulation tests with luteinizing hormone-releasing hormone in polycystic ovarian disease.
Moltz L; Römmler A; Schwartz U; Bidlingmaier F; Hammerstein J
Am J Obstet Gynecol; 1979 Aug; 134(7):813-8. PubMed ID: 380343
[No Abstract] [Full Text] [Related]
20. Role of androgens in the regulation of the human menstrual cycle.
Rossmanith WG; Schenkel B; Benz R
Gynecol Endocrinol; 1994 Sep; 8(3):151-9. PubMed ID: 7847099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
